Imexpharm

Imexpharm Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Imexpharm (IMP.VN) as of Oct 26, 2026 is 171.84. In the previous year, Days Inventory Outstanding (DIO) was 190.70 — a change of -9.89% (lower).

Days Inventory Outstanding

171.84

YoY

-9.89%

Last updated:

Days Inventory Outstanding (DIO) of Imexpharm is 2025 171.84 . Days Inventory Outstanding (DIO) of Imexpharm was 2024 190.70 . It decreases by -9.89% lower compared to the previous year.

The Imexpharm Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2018
165.26 VND
Jan 1, 2019
146.27 VND
Jan 1, 2020
188.29 VND
Jan 1, 2021
230.68 VND
Jan 1, 2022
168.10 VND
Jan 1, 2023
215.71 VND
Jan 1, 2024
190.70 VND
Jan 1, 2025
171.84 VND
The Imexpharm Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
171.84-9.89%
190.70-11.60%
215.71+28.32%
168.10-27.13%
230.68+22.51%
188.29+28.73%
146.27-11.49%
165.26+16.91%
141.35-0.06%
141.44-8.36%
154.35-31.34%
224.80—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Days Inventory Outstanding (DIO) of Imexpharm is 171.84 in 2025.

Days Inventory Outstanding (DIO) of Imexpharm changed from 190.70 to 171.84, representing a -9.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Imexpharm since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Imexpharm with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Imexpharm

All Key Metrics — Imexpharm